cardiovascular pathology (modification of dr. veinot’s presentation)

99
Cardiovascular Pathology (modification of Dr. Veinot’s presentation) Michel Dionne MD FRCPC for John P. Veinot MD FRCPC Professor of Pathology University of Ottawa Pathology and Laboratory Medicine Ottawa Hospital

Upload: hiroko

Post on 07-Jan-2016

61 views

Category:

Documents


1 download

DESCRIPTION

Cardiovascular Pathology (modification of Dr. Veinot’s presentation). Michel Dionne MD FRCPC for John P. Veinot MD FRCPC Professor of Pathology University of Ottawa Pathology and Laboratory Medicine Ottawa Hospital. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Cardiovascular Pathology (modification of Dr. Veinot’s presentation)

Michel Dionne MD FRCPCfor

John P. Veinot MD FRCPCProfessor of PathologyUniversity of Ottawa

Pathology and Laboratory MedicineOttawa Hospital

Page 2: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

You may only access and use this PowerPoint presentation for educational purposes. You may not post this presentation online or distribute it without the permission of the author.

Page 3: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Overview

Atherosclerosis Aneurysms Ischemic heart disease Cardiomyopathies Valvular heart disease Hypertension

Page 4: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

The Growing Burden of Heart Disease and Stroke in Canada 2003

Cerebrovascular Disease (15,409)

7%

Accidents/ Poisoning/ Violence

(13,996)6%

Infectious Diseases (2,583)

1%

Diabetes (6,137)3%

Other (33,240)15%

Respiratory (22,026)10%

AMI (20,926)9.5%

Cancer (62,606)29%

Other CVD (20,914)9.5%

Other IHD (21,693)10%

Figure 4-4 Leading causes of death, number and percentage of deaths, Canada, 1999

All Cardiovascular

Disease (78,942)

36%

Source: Health Canada, using data from Mortality File, Statistics Canada

Total Number of Deaths: 219,530Cardiovascular (ICD-9 390-459); Respiratory (ICD-9 460-519); Diabetes (ICD-9 250); Cancer (ICD-9 140-239); Infectious Diseases (ICD-9 001-139); Accidents/Poisonings/Violence (ICD-9 E800-E999)

Page 5: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

CVS Anatomy 101

Page 6: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Endothelium

Page 7: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

adventitia

intima

media

muscular artery

Page 8: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aorta

Page 9: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Media of aorta – an elastic artery

Page 10: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherosclerosis Disease of large and medium sized arteries

(elastic and muscular), particularly:– aorta, iliac, coronary, popliteal, carotid, circle of

Willis Develop intimal lesions called atheromas or

atheromatous plaques which:– protrude into the lumen resulting in stenosis

(narrowing of lumen) and possibly occlusion (lumen blocked)

– can weaken the underlying media, possibly leading to aneurysm formation

Page 11: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherosclerosis - risk factors

Hyperlipidemia– high LDL

– low HDL Hypertension Smoking Diabetes

Age Male gender Family history/

genetics

Other: physical inactivity, diet, obesity etc.

Page 12: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherosclerosis - pathogenesis Chronic endothelial injury* resulting in endothelial dysfunction

– increased permeability – increased adhesion of leukocytes (monocytes and

lymphocytes) and platelets – accumulation of lipids in intima

Migration of monocytes into intima leading to formation of foam cells (lipid-laden macrophages)

Release of cytokines and growth factors result in smooth muscle cell migration into intima, proliferation of smooth muscle cells, deposition of extracellular matrix (e.g. collagen)

* From hemodynamic forces, hyperlipidemia, HTN, smoking etc.

Page 13: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

From: Robbins and Cotran Pathologic Basis of Disease, 8th Edition

Page 14: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aorta – fatty streaks

Page 15: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 16: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aorta – fibrofatty/atheromatous plaques

Page 17: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aorta – complicated plaques

Page 18: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aortic arch vessels –advanced plaques causing severe stenosis

Page 19: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Coronary artery

Page 20: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atheromatous material – foam cells (lipid laden macrophages) and cholesterol clefts

Page 21: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

From: Robbins and Cotran Pathologic Basis of Disease, 8th Edition

Page 22: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherosclerosis - complications

Calcification Plaque hemorrhage and rupture Plaque erosion/ulceration Thrombosis Embolization of atheromatous

material (atheroemboli) Aneurysm formation and rupture

Page 23: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Renal infarct from embolization

Page 24: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherosclerosis - major consequences

Symptomatic disease most often affects the heart, brain, kidneys and lower extremities– Heart: angina and myocardial infarction– Brain: cerebral infarction (stroke)– Aorta (particularly abdominal):

» Aneurysms» Stenosis of ostia of major branches leading to visceral

ischemia

– Lower extremities: peripheral vascular (arterial) disease – claudication, gangrene

Page 25: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aneurysm - definition

a localized abnormal dilatation of a vessel

Page 26: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aneurysm types

Atherosclerotic aneurysms are the most common, but there are other types!

Page 27: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aneurysms - complications

Stasis of blood Thrombosis

obstruction embolism

Mass effect Rupture

Page 28: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Abdominal Aortic Aneurysm (AAA)

thrombus

Page 29: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aneurysm rupture

thrombus tear

vessel wall

blood

lumen

Page 30: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

AAA rupture

Hemorrhage into surrounding tissue

Page 31: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Dissecting “aneurysm”

Page 32: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Coronary artery aneurysms secondary to vasculitis (inflammation of blood vessels)

Page 33: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Left atrium

Right ventricle

Left ventricle

Right atrium

Pericardium

Right lung

Left lungAortaSVC

Page 34: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Right atrium

Left atrium

Right ventricle

Left ventricle

Interventricular septum

Page 35: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Coronary artery anatomy

http://www.drchander.com/diagnoseCAD.html

Page 36: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Coronary artery atherosclerosis affects the epicardial arteries; tends to be more

pronounced in the proximal portion of these vessels can involve 1, 2 or all 3 of the main vessels +/- their

large branches if degree of obstruction is significant, can result in

angina (pain from myocardial ischemia) an atherosclerotic plaque can become unstable (acute

plaque lesion):– intraplaque hemorrhage– plaque rupture or erosion resulting in thrombosis

acute plaque lesions can result in an “acute coronary syndrome” (unstable angina, myocardial infarct)

Page 37: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 38: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 39: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Myocardial infarct terminology

Page 40: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 41: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 42: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 43: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 44: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Recent MI - about 24 hours old

Page 45: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Contraction band necrosis

Page 46: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Recent MI - about 3 days old

Page 47: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Recent MI - interstitial infiltrate of neutrophils

Page 48: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Recent MI - 5-7 days old

Page 49: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Recent MI - 7-10 days old

Residual necrotic myocytes

Phagocytosis of dead cells at margin of infarct

“Sick” myocytes bordering the infarct

Page 50: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Remote myocardial infarcts

Page 51: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 52: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Transmural rupture

Page 53: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Infarct rupture and tamponade

Page 54: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Papillary muscle rupture

Page 55: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Left ventricle aneurysm

Page 56: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Ischemic heart disease - interventions

Non-surgical thrombolysis PTCA / stenting atherectomy rotablation

Surgical Coronary Artery

Bypass Grafting (CABG) – typically using saphenous vein grafts and/or internal thoracic arteries

endarterectomy

Page 57: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Atherectomy device

Page 58: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

PTCA balloon

Page 59: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 60: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Angiogram pre/post PTCA

Page 61: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 62: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 63: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 64: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aortic valve - normal

Page 65: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Mitral valve - normal

Page 66: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aortic stenosis - causes

Page 67: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Aortic stenosis causing LVH

Page 68: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Mitral stenosis - rheumatic

Page 69: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Floppy mitral valve - mitral valve prolapse (MVP)

Page 70: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Hypertension

PRIMARY (ESSENTIAL)– Genetic and environmental factors– Defects in sodium homeostasis, vascular smooth

muscle structure, regulation of vascular tone SECONDARY

– renal disease– vascular disease– endocrinopathies – drugs– neurogenic etc…

Page 71: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Reno-vascular hypertension

Page 72: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Hypertension - complications

enhance other diseases (risk factor) small vessel changes

– scarring/sclerosis

– microaneurysms

large vessel changes– ectasia / aneurysms / aortic regurgitation

– dissection

vessel rupture cardiac hypertrophy etc…

Page 73: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Arteriolo-nephrosclerosis

Page 74: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Brain hypertensive bleed

Page 75: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Hypertensive brain stem bleed

Page 76: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

LVH (look familiar?)

Page 77: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Cardiomyopathy - definition

Heterogenous group of diseases of the myocardium associated with mechanical or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic.

Cardiomyopathies are either confined to the heart or are part of generalized systemic disorders often leading to cardiovascular death or progressive heart failure related disability.

Circulation 2006 113:1807-1816

Page 78: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Cardiomyopathy types(clinical/functional/morphologic patterns)

Dilated (DCM) – 90% Hypertrophic (HCM) Restrictive

Page 79: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Primary cardiomyopathy (confined to the heart) - etiology

Genetic– e.g. HCM, ARVC, mitochondrial defects,

channelopathies (e.g. LQTS)

Acquired– e.g. due to myocarditis (inflammation of the

myocardium)

Mixed Idiopathic

Page 80: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Secondary cardiomyopathy (part of generalized systemic disorder) – examples of etiologies

Amyloidosis Hemochromatosis Sarcoidosis Medication/Toxin induced - e.g. cancer chemotherapy,

alcoholism Autoimmune diseases - e.g. SLE, rheumatoid arthritis Infections Endocrine disorders - e.g. hypothyroidism Neuromuscular diseases - e.g. muscular dystrophies Storage diseases - e.g. glycogen storage disease Nutritional deficiencies - e.g. thiamine

Page 81: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Primary dilated cardiomyopathy

Primary myocardial abnormality NO SIGNIFICANT:

– coronary artery disease– valve disease– systemic arterial hypertension– systemic disorder, history of toxin exposure

etc.

Page 82: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 83: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 84: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 85: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 86: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Non-specific myocardial degenerative changes

Page 87: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

DCM - clinical presentation

Progressive heart failure– systolic dysfunction– 4 chamber dilatation– hypokinesis

Arrhythmias Thromboembolism Sudden death

Page 88: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Familial (genetic) DCM

About 30 % of DCM Often asymptomatic LV dilatation at

detection - minority progress Examples:

– muscular dystrophy– mitochondrial defects - maternal inheritance– inherited metabolic disorders

Page 89: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Cardiomyopathy – genetic abnormalities

Dilated - cytoskeletal elements largely affected

dystrophin - X-linked, some muscular dystrophies

lamin desmin actin etc…

mitochondrial genes

Hypertrophic - contractile elements affected (sarcomeric genes)

myosin troponin tropomyosin myosin binding protein C etc…

Page 90: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 91: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Viral myocarditis and DCM

Enteroviral protease cleaves dystrophin Disrupted dystrophin / sarcoglycan

complex Similar to primary genetic defects found in

DCM

Page 92: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 93: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Hypertrophic cardiomyopathy

a genetic disease; autosomal dominant, variable penetrance

phenotype variations even with same mutation - ? environmental influences

myocardial hypertrophy (thickened myocardium)

diastolic dysfunction sub-aortic obstruction sudden death (60% of deaths are sudden)

Page 94: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Hypertrophic cardiomyopathy

Disproportionate thickening of the interventricular septum

Page 95: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Myocyte disarray and hypertrophy and interstitial fibrosis

Page 96: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

HCM - diastolic dysfunction

ventricular hypertrophy myocyte disarray interstitial fibrosis myocardial microinfarcts

Page 97: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 98: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)
Page 99: Cardiovascular  Pathology (modification of Dr. Veinot’s presentation)

Cardiomyopathy - summary

Gross and histopathologic findings are non- specific but may be diagnostic

Most require clinicopathological correlation Many mimics and secondary diseases Molecular diagnosis / genetics developing